Noul Showcases AI Cervical Cancer Screening at NVIDIA GTC 2025
Noul Co., Ltd. showcased its AI-powered cervical cancer screening technology at the NVIDIA GTC 2025 conference. Announced in a press release, the company presented a poster titled "Bridging Medical Gaps from Malaria to Cancer: On-Device AI Diagnostic Solutions Powered by NVIDIA Jetson," highlighting its miLab™ CER platform.
The miLab™ CER is a compact, fully automated diagnostic device that performs sample staining, digital imaging, and AI-powered result analysis, delivering results in just 15 minutes. This platform, powered by NVIDIA Jetson, aims to improve diagnostic accessibility in underserved regions and centralized healthcare systems.
Noul's participation in the NVIDIA Healthcare & Life Sciences partner ecosystem marks a significant step in advancing AI's role in global healthcare delivery. The miLab™ CER platform was previously recognized by WHO-UNITAID as one of the top global diagnostic products for cervical cancer triage.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish like Life AI Weekly.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation
The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.
Read more